Bolt Biotherapeutics, Inc.
BOLT
$4.54
-$0.10-2.05%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 47.12% | 34.42% | 23.35% | -0.51% | 8.79% |
| Total Depreciation and Amortization | -27.51% | -19.76% | -12.58% | -6.67% | -3.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -48.75% | -35.05% | -32.84% | -1.46% | 10.49% |
| Change in Net Operating Assets | -43.54% | -92.81% | 0.41% | 60.87% | 14.44% |
| Cash from Operations | 34.98% | 22.90% | 19.64% | 7.91% | 11.85% |
| Capital Expenditure | -75.61% | -53.19% | 76.02% | 79.80% | 80.10% |
| Sale of Property, Plant, and Equipment | 550.68% | 550.68% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -24.46% | -10.62% | -5.63% | 16.02% | -19.33% |
| Cash from Investing | -23.05% | -9.31% | -3.46% | 18.51% | -18.95% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -82.41% | -76.76% | -76.76% | -57.31% | -57.31% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -82.41% | -76.76% | -76.76% | -57.31% | -57.31% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 224.02% | 3,815.42% | 148.22% | 139.80% | -304.13% |